GENOVA, Inc.

2026/08/10 Updated
Market Cap: $70.0M (¥11.1B)
Stock Price: $4.04 (¥638)
Exchange Rate: 1 USD = ¥157.98

First Quarter Consolidated Financial Results for the Fiscal Year Ending March 2027 (Japanese GAAP) (Consolidated)

Announces the consolidated results for the first quarter of the fiscal year ending March 2027. Revenue increased year over year, with the Medical Platform and Smart Clinic segments contributing to solid performance. The financial position shows asset growth, liabilities growth, and an increase in net assets. Full-year guidance will be disclosed in subsequent materials; an earnings briefing is planned to be released as a separate document.

Importance:
Page Updated: August 10, 2026
IR Disclosure Date: August 10, 2026

Key Figures

  • Revenue: Unknown
  • Cost of sales: Unknown
  • Gross profit: Unknown

AI要約

Overview of Performance

This quarter's consolidated results show favorable segment trends centered on revenue. In particular, the Medical Platform and Smart Clinic segments are tracking positively, while the movements of cost of sales and selling, general and administrative expenses warrant close monitoring. Group-wide assets are increasing, and changes are observed in the composition of liabilities and net assets. The full-year outlook is scheduled to be disclosed with additional materials at the earnings briefing.

Impact on Shareholders / Outlook

Quarterly earnings guidance and segment contributions will depend on upcoming disclosed materials. At this stage, major financial figures are not yet finalized, but the quarterly earnings forecast is expected to be included in the financial results summary. Investors should monitor segment revenue mix and profitability trends, as well as changes in capital structure (asset growth, liability growth, and net asset growth).

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

GENOVA Corporation

Company overview · Stock price · Financial data · All IR

View company page →